Fernando Ferrando - Concepedia

Author

Fernando Ferrando

Hospital Universitari i Politècnic La Fe

Also Known As

F Ferrando, F. FERRANDO, F. Ferrando, F. Riu Ferrando, Fernando Ferrando, Piedad Villa, Vicenta Martínez-Sales, Yolanda Mira

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari i Politècnic La Fe Leitat Technological Center Instituto de Investigación Sanitaria La Fe Sociedad Española de Trombosis y Hemostasia Art Research Centre of the Slovak Academy of Sciences

About

Fernando Ferrando is an author at Hospital Universitari i Politècnic La Fe specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	341
2	Public Health	6	6	216
3	Health Sciences	1	1	24
4	Cell Biology	1	1	24
5	Diabetes	1	1	24

Fernando Ferrando

Publications

792

Citations

H-Index

Page 1

	Year	Citations
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects Rafael Giner Seguí, Amparo Estellés, Yolanda Mira, British Journal of Haematology Genetic Thrombophilic DefectsHealthy SubjectsImpaired FibrinolysisGeneticsGenetic Epidemiology	2000	100
Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk Pilar Medina, Silvia Navarro, Amparo Estellés, Thrombosis and Haemostasis	2004	100
Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors Amparo Vayá, Yolanda Mira, Fernando Ferrando, British Journal of Haematology	2002	93
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. José A. Aznar, Amparo Vayá, A. Estellés, PubMed	2000	85
Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation Silvia Navarro, Pilar Medina, Yolanda Mira, Haematologica	2008	48
Increase of Neutrophil Activation Markers in Venous Thrombosis—Contribution of Circulating Activated Protein C Laura Martos, Júlia Oto, Álvaro Fernández‐Pardo, International Journal of Molecular Sciences	2020	38
Hereditary Homozygous Heparin Cofactor II Deficiency and the Risk of Developing Venous Thrombosis Piedad Villa, Amparo Vayá, Francisco España, Thrombosis and Haemostasis Family MembersGeneticsGenetic EpidemiologyImmunologyPathology	1999	33
Association of the Thrombomodulin Gene c.1418C>T Polymorphism With Thrombomodulin Levels and With Venous Thrombosis Risk Silvia Navarro, Pilar Medina, Elena Bonet, Arteriosclerosis Thrombosis and Vascular Biology	2013	32
Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation. Amparo Vayá, MJ Forner, A. Estellés, PubMed ImmunologyGenetic EpidemiologyPathologyRight Intracardiac ThrombosisIntracardiac Thrombosis	2000	32
Elevated Thrombotic Activity after Myocardial Infarction: A 2-Year Follow-Up Study Vicenta Martı́nez-Sales, V. Vila, E. Regañón, Pathophysiology of Haemostasis and Thrombosis Persistent GenerationPharmacotherapyAcute Myocardial InfarctionThrombosisVenous Thrombosis	1998	30

Page 1